(VIANEWS) – SPBK 1 ØSTLANDET (SPOL.OL), NEURONES (NRO.PA), SANOFI (SAN.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. SPBK 1 ØSTLANDET (SPOL.OL)
56.62% Payout Ratio
SpareBank 1 Østlandet provides various financial products and services to individuals, businesses, the public sector, clubs, and societies. The company operates through Retail, Corporate, and Organisation Market and Capital Market segments. The Retail segment provides financial services comprising of savings, money transfer, insurance, accident prevention, financing, money transfer, capital, and investment management services. The Corporate segment offers interest rate, currency hedging, and investment related services, as well as insurance services for property. The Organisation Market and Capital Market segment provides risk based advisory solutions to high-net-worth individuals and corporates, as well as engages in foreign currency services. SpareBank 1 Østlandet was founded in 1845 and is headquartered in Hamar, Norway. The company operates as a subsidiary of Sparebankstiftelsen Hedmark.
Earnings Per Share
As for profitability, SPBK 1 ØSTLANDET has a trailing twelve months EPS of kr12.01.
PE Ratio
SPBK 1 ØSTLANDET has a trailing twelve months price to earnings ratio of 10.47. Meaning, the purchaser of the share is investing kr10.47 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.98%.
More news about SPBK 1 ØSTLANDET.
2. NEURONES (NRO.PA)
54.95% Payout Ratio
Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, manages public and private cloud services, IT operations, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of SAP, digital, WEB, mobility, UX/UI, enterprise content and document management, business process management, robotic process automation, dematerialization, IT consulting for finance, big data, and DevOps, IT training and change management, and Innovation connected devices (IOT). In addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, DevOps, CI/CD, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, UX/UI, and digital marketing, as well as internal process digitization, ECM/BPM, RPA, dematerialization, AI, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. The company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. Neurones S.A. was founded in 1984 and is based in Nanterre, France.
Earnings Per Share
As for profitability, NEURONES has a trailing twelve months EPS of €1.82.
PE Ratio
NEURONES has a trailing twelve months price to earnings ratio of 20.88. Meaning, the purchaser of the share is investing €20.88 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.2%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 14, 2023, the estimated forward annual dividend rate is 1.1 and the estimated forward annual dividend yield is 2.81%.
More news about NEURONES.
3. SANOFI (SAN.PA)
50.08% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €6.65.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 14.75. Meaning, the purchaser of the share is investing €14.75 for every euro of annual earnings.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 46.2B for the twelve trailing months.
More news about SANOFI.
4. QUADIENT (QDT.PA)
30.51% Payout Ratio
Quadient S.A. provides intelligent communication automation, mail-related, and parcel locker solutions for customers through digital and physical channels in North America, France, Benelux, the United Kingdom, Ireland and Germany, Austria, Italy, Switzerland, and internationally. It provides Quadient Inspire, a software solution that facilitates the creation and management of transactional and marketing communication documents, as well as manages omnichannel delivery for the communications; Quadient Impress, a cloud-based software that facilitates outbound document automation; YayPay, account receivable process automation solutions; and Beanworks, an accounts payable automation software solution. The company also offers Quadient Inspire Flex, which enables organizations to create and deliver personalized, compliant customer communications across various channels from one centralized platform; Quadient DigitalBOOST, a suite of pre-packaged solutions that digitalizes customer processes and contracts; and Quadient Inspire Journey, a cloud-based journey mapping solution that integrates customer journey mapping, data, and communications technologies. In addition, it supplies software, equipment, and services for managing incoming and outgoing mails; and provides hardware and software platform that facilitates invoicing and customer communications, multi-channel mail processing, last-mile parcel delivery, and the consolidation of their return. Further, the company operates a pick-up, drop-off solution that offers businesses and people who need to manage their deliveries and returns. It serves financial services, healthcare, higher education, insurance, and retail industries, as well as service providers industries. The company was formerly known as Neopost S.A. and changed its name to Quadient S.A. in September 2019. Quadient S.A. was founded in 1924 and is headquartered in Bagneux, France.
Earnings Per Share
As for profitability, QUADIENT has a trailing twelve months EPS of €1.8.
PE Ratio
QUADIENT has a trailing twelve months price to earnings ratio of 11.17. Meaning, the purchaser of the share is investing €11.17 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.29%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 3, 2023, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 3.04%.
Yearly Top and Bottom Value
QUADIENT’s stock is valued at €20.10 at 02:10 EST, above its 52-week high of €20.05.
Volume
Today’s last reported volume for QUADIENT is 7338 which is 73.42% below its average volume of 27614.
More news about QUADIENT.
